Navigation Links
Cholesterol-lowering therapy benefits older people also

According to a new study it is observed that statins reduce the risk of heart attack in older people. Long-term treatment with statins lowers cholesterol// levels and so lowers the risk of heart disease. This has been shown to be the case in middle-aged people, but the benefits for the elderly have not been so clear.

Researchers at the University of Glasgow have assessed the benefit of treatment with the statin drug pravastatin in a group of 4,050 men and women aged between 75 and 80 years, all at high risk of heart attack or stroke. Half received pravastatin and half a placebo and all were followed up for an average of just over three years.

Pravastatin lowered low density lipoprotein (LDL, or 'bad' cholesterol) by about a third, and reduced a combination of coronary death, non-fatal heart attack and stroke by 16 per cent. Closer analysis shows that death from heart disease was reduced by 20 per cent, while stroke risk was unaffected. Lucidly, people of all ages can benefit from long-term statin therapy. All patients at high risk of heart disease should now be offered statins to improve their survival and future health.


'"/>




Page: 1

Related medicine news :

1. Cholesterol-lowering drug Found To greatly Reduce the risk of stroke and heart attack
2. Growing Popularity of Cholesterol-lowering Drugs Raises Concern
3. Cholesterol-lowering Drug Effective at Halting Early Atherosclerosis
4. Acupuncture May Help Chemotherapy Side Effects
5. Antioxidants protect health tissue in people undergoing radiation therapy.
6. Distraction therapy found very effective in postoperative patients
7. Acupuncture superseeds massage therapy for short term relief of pain
8. Ovarian cancer in relationship with Hormone therapy
9. New therapy better at increasing bone density
10. Gene therapy - Aim to improve blood flow
11. Gene therapy restores sight
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... MD (PRWEB) , ... October 12, 2017 , ... The ... of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual ... – 8. , In honor of Morris F. Collen, a pioneer in the field ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: